Contact

Cautera Home About Services Evidence Review Safety & Risks What to Ask Contact Evidence, uncertainty & safety clarity Does Ibogaine Treatment Work The clearest answer is cautious: ibogaine can show a real short-term signal for opioid withdrawal and cravings, but it is not proven as a durable addiction treatment and carries substantial cardiac risk. This independent resource is for people affected by substance use, families, and others seeking clear context. It does not promote treatment or replace medical or legal advice. In this guide What it is What evidence shows Process & outcomes Safety first Legal status Key questions A promising signal is not the same as proof Ibogaine treatment has drawn attention because some people report fast relief from severe withdrawal and drug cravings. Research suggests there may be meaningful short-term therapeutic effects, particularly for opioid addiction, but durable outcomes have not been established by randomized placebo-controlled clinical trials. For a broader starting point, the main evidence overview on ibogaine treatment follows the same distinction: a striking detox process can matter without proving long-term sobriety or patient safety. What the compound does—and does not settle Origin, mechanism, and why an intense experience should not be confused with a treatment outcome. Ibogaine is a naturally occurring psychoactive alkaloid found in the root bark of the Tabernanthe iboga plant, a natural plant native to Central West Africa. Its pharmacological background includes traditional use and modern interest as a mind-altering plant medicine. Ibogaine treatment primarily functions as a dissociative psychedelic, influencing multiple neurotransmitter systems including opioid, serotonin, and dopamine receptors. These neurological effects involve the central nervous system and brain chemistry in ways that are not fully resolved. The psychedelic experience can be lengthy, psychologically demanding, and very different

Contact

A note on the scope of this site